Lightship makes true clinical trial accessibility a reality for patients and providers, accelerating the development of better therapies for all. We achieve this by building accessibility into trial design from the very beginning, making it easier for patients and caregivers to participate. Through use of inclusive technology and flexible on-site, at home, and hybrid trial visits, Lightship creates a positive clinical research experience, all while maintaining an unwavering commitment to quality.

Our CEO, David MacMurchy, and Co-Founder, Samantha Eells, will be in San Francisco during J.P. Morgan. Reach out to schedule some time to learn more about our mission of creating more access in clinical trials.